CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure Empagliflozin, Health Status, and Quality of Life in Patients with Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensus SGLT2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis of the EMPEROR-Reduced and DAPA-HF Trials Heart failure with preserved ejection fraction: from mechanisms to therapies

Original ResearchVolume 7, Issue 6, June 2019

JOURNAL:JACC: Heart Failure Article Link

Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF

C Balmforth, J Simpson, L Shen et al. Keywords: angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; etiology; heart failure; natriuretic peptide; sneprilysin; treatment

FULL TEXT PDF